1 / 10

PharmDr. Tomas Tesar, PhD.

Faculty of pharmacy. Comenius University. Bratislava. 22nd October 2007. Drug policy and pharmacoeconomics within the Slovak Republic. ISPOR Local Chapter Slovakia. PharmDr. Tomas Tesar, PhD. source : http://www.oecd.org/dataoecd/46/36/38979632.xls [ 12.10.2007 ].

caldwell-flores
Download Presentation

PharmDr. Tomas Tesar, PhD.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Faculty of pharmacy Comenius University Bratislava 22nd October 2007 Drug policy and pharmacoeconomics within the Slovak Republic ISPOR Local Chapter Slovakia PharmDr. Tomas Tesar, PhD.

  2. source: http://www.oecd.org/dataoecd/46/36/38979632.xls [12.10.2007]

  3. ◘In June 2003, legal amendments dramatically changed the drug categorization system. The number of ATC groups in which at least one drug has to be fully reimbursed by law decreased to 122.

  4. ◘The composition of the categorization committee was changed, with greater participation of health insurance companies΄ representatives and a higher emphasis on cost-effectiveness analysis.

  5. ◘Generic substitution, maximum prices, price monitoring in the reference countries are implemented within the Slovak’s drug policy and introduction of a degressive margin is prepared.

  6. Problems: The cost – effectiveness threshold is not agreed. an example: 433 % 1208 %

  7. The majority of HTA are transfrered. however Not all participated parties within reimbursement process determine 14 transferability factors: ◘ To which content it is relevant for the investigated technology ◘ How much it corresponds between the study and country’s decision ◘ The likely effect of the transferability factor on the cost-effectiveness ratio

  8. ◘Inconsistent reimbursement decisions can be consider as one of the main reasons for the accumulation of expenditures on drugs within the Slovak Republic. ◘The principe “VALUE FOR MONEY” as a reasonable criterion for making resource allocation decision within the health care system should be implemented more deeply.

  9. THANK YOU FOR YOUR ATTENTION

  10. END KONEC КОНЕЦ ENDE FIN KONIEC FINE

More Related